Cantor Fitzgerald restated their buy rating on shares of Omega Healthcare Investors (NYSE:OHI) in a report published on Tuesday morning. The firm currently has a $34.00 price objective on the real estate investment trust’s stock.

“Revising 2018 estimates. We are reducing our 2018 revenue estimate to $910 million from $943 million to reflect OHI’s fourth-quarter asset sales, assets held for sale, and an additional $300 million of potential asset dispositions in 2018. We are reducing our 2018 FFO estimate to $2.95 from $3.11 and reducing our 2018 AFFO estimate to $3.03 from $3.26. That said, we will revisit our estimates after the Feb. 14 morning earnings call.”,” Cantor Fitzgerald’s analyst wrote.

Several other equities research analysts also recently weighed in on OHI. Vetr downgraded shares of Omega Healthcare Investors from a buy rating to a hold rating and set a $33.33 price objective for the company. in a report on Thursday, October 19th. Capital One Financial initiated coverage on shares of Omega Healthcare Investors in a report on Monday, October 23rd. They issued an equal weight rating and a $34.00 price objective for the company. Stifel Nicolaus downgraded shares of Omega Healthcare Investors from a buy rating to a hold rating and reduced their price objective for the stock from $35.00 to $29.00 in a report on Tuesday, October 31st. TheStreet downgraded shares of Omega Healthcare Investors from a b- rating to a c rating in a report on Monday, October 30th. Finally, Hilliard Lyons downgraded shares of Omega Healthcare Investors to a buy rating in a report on Wednesday, November 1st. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $31.85.

Omega Healthcare Investors (NYSE:OHI) opened at $26.96 on Tuesday. The company has a market cap of $5,320.00, a PE ratio of 35.47, a PEG ratio of 2.70 and a beta of 0.41. The company has a current ratio of 3.40, a quick ratio of 3.40 and a debt-to-equity ratio of 1.18. Omega Healthcare Investors has a 12-month low of $24.90 and a 12-month high of $35.14.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Wednesday, January 31st will be issued a $0.66 dividend. The ex-dividend date is Tuesday, January 30th. This represents a $2.64 annualized dividend and a yield of 9.79%. This is an increase from Omega Healthcare Investors’s previous quarterly dividend of $0.65. Omega Healthcare Investors’s dividend payout ratio is presently 347.37%.

In other Omega Healthcare Investors news, Director Bernard J. Korman purchased 100,000 shares of the business’s stock in a transaction on Friday, December 22nd. The stock was bought at an average cost of $26.89 per share, with a total value of $2,689,000.00. Following the acquisition, the director now owns 896,895 shares of the company’s stock, valued at $24,117,506.55. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.54% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. BlackRock Inc. lifted its holdings in Omega Healthcare Investors by 2.1% in the 4th quarter. BlackRock Inc. now owns 21,258,742 shares of the real estate investment trust’s stock valued at $585,466,000 after acquiring an additional 438,005 shares during the last quarter. State Street Corp lifted its holdings in Omega Healthcare Investors by 4.3% in the 2nd quarter. State Street Corp now owns 6,278,985 shares of the real estate investment trust’s stock valued at $207,335,000 after acquiring an additional 258,035 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in Omega Healthcare Investors by 0.9% in the 3rd quarter. Principal Financial Group Inc. now owns 5,554,583 shares of the real estate investment trust’s stock valued at $177,245,000 after acquiring an additional 50,760 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Omega Healthcare Investors by 11.8% in the 4th quarter. Bank of New York Mellon Corp now owns 4,408,364 shares of the real estate investment trust’s stock valued at $121,406,000 after acquiring an additional 466,377 shares during the last quarter. Finally, LSV Asset Management lifted its holdings in Omega Healthcare Investors by 106.1% in the 4th quarter. LSV Asset Management now owns 4,006,633 shares of the real estate investment trust’s stock valued at $110,342,000 after acquiring an additional 2,062,428 shares during the last quarter. 67.90% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://theolympiareport.com/2018/02/14/omega-healthcare-investors-ohi-given-buy-rating-at-cantor-fitzgerald.html.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.